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The WNT signaling enhancer R-spondin3 (RSPO3)
is prominently expressed in the vasculature. Corre-
spondingly, embryonic lethality of Rspo3-deficient
mice is caused by vessel remodeling defects. Yet
the mechanisms underlying vascular RSPO3 func-
tion remain elusive. Inducible endothelial Rspo3
deletion (Rspo3-iECKO) resulted in perturbed devel-
opmental and tumor vascular remodeling. Endothe-
lial cell apoptosis and vascular pruning led to re-
duced microvessel density in Rspo3-iECKO mice.
Rspo3-iECKO mice strikingly phenocopied the
non-canonical WNT signaling-induced vascular de-
fects of mice deleted for the WNT secretion factor
Evi/Wls. An endothelial screen for RSPO3 and EVI/
WLS co-regulated genes identified Rnf213, Usp18,
and Trim30a. RNF213 targets filamin A and NFAT1
for proteasomal degradation attenuating non-
canonical WNT/Ca2+ signaling. Likewise, USP18
and TRIM5a inhibited NFAT1 activation. Conse-
quently, NFAT protein levels were decreased in
endothelial cells of Rspo3-iECKO mice and pharma-
cological NFAT inhibition phenocopied Rspo3-
iECKO mice. The data identify endothelial RSPO3-
driven non-canonical WNT/Ca2+/NFAT signaling as
a critical maintenance pathway of the remodeling
vasculature.DeveINTRODUCTION
WNT signaling plays a critical role in developmental processes
such as axis formation and organogenesis by controlling cell
proliferation, apoptosis, migration, polarization, and stem cell
differentiation (Niehrs, 2012). At least three WNT signaling path-
ways have been described so far. Activation of the canonical
WNT pathway releases b-catenin from its destruction complex,
which subsequently translocates into the nucleus and switches
on target gene expression (Nusse, 2012). The non-canonical
pathways include WNT/planar cell polarity (PCP) and WNT/
calcium (Ca2+ signaling). Activation of the WNT/Ca2+ pathway
results in elevated intracellular Ca2+ levels. Ca2+ ions activate
the phosphatase calcineurin, which dephosphorylates the tran-
scription factor nuclear factor of activated T cells (NFAT), thereby
promoting its nuclear import (De, 2011).
The WNT signaling pathways are activated by binding of WNT
ligands to Frizzled (FZD) receptors, which cooperate with several
FZD co-receptors such as LRP5/6 and syndecan (Niehrs, 2012).
Beyond the FZD co-receptors, WNT signaling is also controlled
by secreted WNT activators and inhibitors such as R-spondins
and Dickkopf proteins, respectively (Cruciat and Niehrs, 2013).
The R-spondins are a family of four secreted proteins, which
enhance WNT signaling through different mechanisms. The
ubiquitin ligases ZNRF3 and RNF43 promote lysosomal degra-
dation of FZD and LRP6. Binding of the R-spondin/LGR4
complex to ZNRF3 and RNF43 leads to their subsequent mem-
brane clearance, thereby stabilizing FZD and LRP6 at the cell
membrane (Hao et al., 2012; Koo et al., 2012). Furthermore,
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enhances canonical and WNT/PCP signaling, respectively, by
increasing WNT-FZD complex internalization (Glinka et al.,
2011; Ohkawara et al., 2011).
R-spondin gene transcripts display distinct expression patterns
during development, suggesting that the site of expression deter-
mines the in vivo function of a particular R-spondin (Nam et al.,
2007b). Accordingly, the R-spondins exert distinctly different
functions in vivo despite their common domain architecture and
mechanism of potentiating WNT signaling (de Lau et al., 2012).
R-spondin1 (RSPO1) is involved in sex determination (Tomizuka
et al., 2008), RSPO2 in hindlimb development (Nam et al.,
2007a), RSPO3 in vascular development (Kazanskaya et al.,
2008), and RSPO4 in nail development (Bergmann et al., 2006).
WNT signaling has been described to control vascular
morphogenesis. b-Catenin gain- and loss-of-function mutants
show impaired embryonic vessel formation and patterning (Cor-
ada et al., 2010), and non-canonical WNT signaling regulates
endothelial cell (EC) proliferation and vascular network formation
(Cheng et al., 2008; Descamps et al., 2012). Several studies have
reported a paracrine role of WNT ligands in blood vessel forma-
tion (Lobov et al., 2005; Stefater et al., 2011). However, little
is known about the role of EC as a source for WNT ligands
(Goodwin et al., 2006). We have recently shown that EC-derived
non-canonical WNT ligands control retinal and tumor blood
vessel remodeling in an EC-autonomous manner by deleting
the WNT secretion factor Evenness Interrupted/Wntless (Evi/
Wls) from EC (Korn et al., 2014). The seven-pass transmembrane
receptor EVI/WLS is an essential component of the Wnt secre-
tion machinery and is required for pan-Wnt protein exocytosis
from the ER to the cell surface (Bartscherer et al., 2006; Yu
et al., 2014).
R-spondins are widely co-expressed with WNT ligands, and
R-spondin gene expression correlates with increased WNT
signaling (Kamata et al., 2004), suggesting that blood vessel sta-
bility may be positively controlled by the concerted action of
WNT ligands and R-spondins co-expressed by EC. The expres-
sion of Rspo3 in highly vascularized tissues such as the allantois
and the primitive streak (Nam et al., 2007b), and the vascular
phenotype of Rspo3 mutant mice indicate a major function of
RSPO3 in EC. This study was consequently aimed at elucidating
the role of EC-derived RSPO3 in blood vessel formation and
remodeling.
RESULTS
Endothelial Cells Are a Major Source of RSPO3
Rspo3 is expressed in highly vascularized tissues such as the
allantois and the primitive streak (Nam et al., 2007b), indicating
Rspo3 expression in EC or mural cells. More recently, Rspo3
expression has been explicitly demonstrated in human and
mouse EC (Kannan et al., 2013). To exclude mural cells as major
source for RSPO3, we compared RSPO3 gene expression in hu-
man brain microvascular endothelial cells (HBMEC) and human
brain vascular pericytes (BP). RSPO3 was expressed 35-fold
higher in HBMEC than in BP (Figure 1A), confirming EC as the
major vascular source for RSPO3 in human. Similarly, mouse
Rspo3 was more strongly expressed in isolated lung, heart,
and kidney EC compared with corresponding pericyte popula-
tions (Figures 1B, S1A, and S1B).80 Developmental Cell 36, 79–93, January 11, 2016 ª2016 Elsevier InLoss of Endothelial RSPO3 Is Causative for the Lethality
of Global Rspo3-Deficient Mice
To study the contribution of EC-derived RSPO3 on the lethal
phenotype of global Rspo3-deficient mice, we crossed floxed
Rspo3 mice to Sox2Cre mice (Figure 1C) or to Cdh5Cre mice
(Figure 1D), resulting in global (Rspo3-KO) or EC-specific dele-
tion of Rspo3 (Rspo3-ECKO), respectively. Rspo3-KO and
Rspo3-ECKO mice showed embryonic lethality. Corresponding
to Rspo3 constitutive mutants (Kazanskaya et al., 2008),
Sox2Cre-driven Rspo3-KO mice arrested in development at
embryonic day 10.5 (E10.5) and showed vascular defects such
as pale placentas (Figures 1E and 1F). Lethality of Rspo3-
ECKO mice was slightly retarded. Approximately 50% of
Rspo3-ECKO embryos also arrested in development at E10.5
(Figures 1G and 1H), whereas the remaining embryos survived
maximally until E13.5. Similarly to global Rspo3-deficient mice
(Aoki et al., 2007; Kazanskaya et al., 2008), placentas of
Rspo3-ECKO embryos, which arrested in development at
E10.5, showed a reduced thickness of the labyrinth layer
compared with Rspo3 wild-type (-WT) placentas. Moreover,
the branched morphology of the labyrinth layer was disturbed
in Rspo3-ECKO embryos (Figures S1C and S1D). RSPO3 is
also expressed in the developing heart, and deletion of Rspo3
from the pre-cardiac mesoderm results in embryonic lethality
around E11.5 with cardiac defects evident as early as E10.5
(Cambier et al., 2014). These data indicate that the slightly
attenuated phenotype of Rspo3-ECKO mice compared with
Rspo3-KO embryos may have resulted from additional cardiac
defects in Rspo3-KO embryos. Together, the data suggest auto-
crine regulation of developmental blood vessel formation by
endothelial RSPO3.
EC-Derived RSPO3 Regulates Blood Vessel Density in
the Postnatal Retina
To overcome the embryonic lethality of Rspo3-ECKO mice, we
crossed floxed Rspo3 mice to Cdh5CreERT2 mice (Figure 2A),
resulting in tamoxifen-inducible EC-specific deletion of Rspo3
(Rspo3-iECKO). Postnatal tamoxifen delivery was performed to
study the impact of EC-derived RSPO3 on developmental blood
vessel formation in the retina angiogenesis model (Figure 2B).
This model is suitable to analyze the different phases of angio-
genesis: vessel sprouting, maturation, and remodeling/pruning.
During vessel sprouting, tip cell migration is followed by pro-
liferation of stalk cells. The sprouts mature by deposition of a
basement membrane (BM) and recruitment of pericytes. Finally,
excessive vessels undergo regression to meet the metabolic
demand of the tissue (Korn and Augustin, 2015).
Vessel sproutingwas not affected uponEC-specific deletion of
Rspo3 as indicated by unaltered tip cell behavior (Figure 2C), the
same levels of stalk cell proliferation in Rspo3-iECKO compared
with Rspo3-WT mice (Figures S2A and S2B), and only a minor
reduction of the vascularized area (total surface area; Figure 2D
[surrounded by red line]). In contrast, a more pronounced reduc-
tion of vessel area (area covered by vessels; Figure 2E) and mi-
crovessel density (ratio of vessel area to vascularized area) was
detected in Rspo3-iECKO mice (Figure 2F). The altered vascular
pattern was associated with a reduced number of vascular
branches and branch points, resulting in a significant reduction
of vascular network complexity in Rspo3-iECKO retinas (Figuresc.
Figure 1. RSPO3 Expression and Function in Endothelial Cells
(A) Gene expression analysis of RSPO3 in HBMEC and BP (n = 3). GAPDH was used as a housekeeping gene.
(B) Gene expression analysis of Rspo3 in isolated EC and PC (n = 3) of mouse lungs, hearts, and kidneys. Hprt was used as a housekeeping gene.
(C and D) Schematic diagram of global Rspo3 deletion (C) and of EC-specific deletion of Rspo3 (D).
(E–H) Rspo3-WT (E) versus Rspo3-KO (F) and Rspo3-WT (G) versus Rspo3-ECKO (H) embryos and placentas at E10.5.
Scale bars, 1 mm. Data are depicted as mean + SD. p < 0.05 was considered statistically significant. *p < 0.05, ***p < 0.001.
See also Figure S1 for EC and pericyte isolation scheme as well as placental defects of Rspo3-ECKO embryos.2G and 2H). Moreover, the decrease in vessel density correlated
with a decrease in the total number of EC analyzed by staining for
the EC-specific transcription factor ERG1 (Figures 2I and 2J). The
number of EC per vessel area was consistent in both Rspo3-WT
and Rspo3-iECKO mice (Figure 2K), implying that EC in Rspo3-
iECKO retinas were able to cover the same vessel area as EC
in Rspo3-WT retinas. Pericyte coverage was not altered in the
retinal vasculature of Rspo3-iECKOmice, suggesting that vesselDevematuration was not affected (Figures S2C and S2D). Together,
the data suggest a role of RSPO3 in the control of vessel remod-
eling rather than vessel sprouting and maturation.
EC-Derived RSPO3 Regulates Microvessel Remodeling
and EC Apoptosis
Blood vessels constrict in the course of vessel regression and EC
retract, leaving behind empty BM sleeves (Korn and Augustin,lopmental Cell 36, 79–93, January 11, 2016 ª2016 Elsevier Inc. 81
Figure 2. Reduced Blood Vessel Density in Rspo3-iECKO versus Rspo3-WT Mice
(A) Schematic diagram of inducible EC-specific deletion in Rspo3-iECKO mice.
(B) Scheme of tamoxifen induction in Rspo3-WT and Rspo3-iECKO mouse pups.
(C) Sprouting front stained with IB-4 (green) in Rspo3-WT and Rspo3-iECKO mice.
(D) Total retinal vasculature stained with IB-4 (green) in Rspo3-WT and Rspo3-iECKO mice. The vascularized area is highlighted by a red line.
(E and F) Analysis of the relative vascularized area: vessel area (E) (n = 20) and vessel density (F) (n = 17).
(G and H) Analysis of the relative number of branches (G) (n = 15) and junctions (H) (n = 15).
(I) Retinal vasculature stained with IB-4 (green) and for ERG1 (red) in Rspo3-WT and Rspo3-iECKO mice.
(J and K) Analysis of the relative number of ERG1-positive EC per retina area (J) (n = 13) and per vessel area (K) (n = 13).
Scale bars, 1 mm (D) and 100 mm (C and I). Data are depicted as mean + SD. p < 0.05 was considered statistically significant. *p < 0.05, **p < 0.005, ***p < 0.001.
See also Figure S2 for EC proliferation and vessel maturation in Rspo3-iECKO versus Rspo3-WT mice.2015). Concomitantly, blood vessel regression leads to the
upregulation of vasoconstrictory genes (Lobov et al., 2011).
The retinal vasculature of Rspo3-iECKO mice had significantly
higher numbers of empty type IV collagen (ColIV) BM sleeves
(Figures 3A and 3B, arrowheads), suggesting a role of endothelial
RSPO3 in controlling the switch between vessel maintenance
and vessel regression. Likewise, expression of the vasoconstric-
tory genes endothelin receptor type A (Ednra) and angiotensi-82 Developmental Cell 36, 79–93, January 11, 2016 ª2016 Elsevier Innogen (Agt) was upregulated in EC isolated from Rspo3-iECKO
mice (Figure 3C). The increase in blood vessel regression corre-
lated with an increase in EC apoptosis in Rspo3-iECKO mice, as
indicated by an elevated number of terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labeling (TUNEL)-positive
EC (Figures 3D and 3E). In addition, the apoptosis-related
gene Stat2 was upregulated in EC isolated from Rspo3-iECKO
mice (Figure 3F).c.
Figure 3. Increased Blood Vessel Regression and EC Apoptosis in Rspo3-iECKO versus Rspo3-WT Mice
(A) Retinal vasculature stained with IB-4 (green) and for ColIV (red) in Rspo3-WT and Rspo3-iECKOmice. Empty ColIV BM sleeves are indicated by arrowheads.
(B) Analysis of the relative number of empty ColIV BM sleeves (n = 21).
(C) Gene expression analysis of lung EC Ednra and Agt from Rspo3-WT and Rspo3-iECKO mice, with b-actin (bact) used as housekeeping gene (n = 11).
(D) Retinal vasculature stained with IB-4 (green) and by TUNEL assay (red) in Rspo3-WT and Rspo3-iECKO mice. Apoptotic EC are indicated by arrowheads.
(E) Analysis of the relative number of apoptotic EC (n = 21).
(F) Gene expression analysis of lung EC Stat2 from Rspo3-WT and Rspo3-iECKO mice, with bact used as housekeeping gene (n = 11).
(G) Gene expression analysis of RSPO3, STAT2, and TEK in HUVEC treated with siRNA against RSPO3 (n = 6). HPRT was used as housekeeping gene.
Scale bars, 100 mm. Data are depicted as mean + SD. p < 0.05 was considered statistically significant. *p < 0.05, **p < 0.005, ***p < 0.001.To investigate a possible EC-autonomous regulation of EC
apoptosis by RSPO3 and to exclude effects of bystander cells,
we silenced RSPO3 in human umbilical vein endothelial cells
(HUVEC) using two different small interfering RNAs (siRNAs).
Similar to the in vivo phenotype, STAT2 was upregulated upon
RSPO3 silencing. Moreover, the EC survival signaling receptor
TEK/TIE2 (Augustin et al., 2009) was downregulated upon
siRNA-mediated silencing of RSPO3 (Figure 3G). Together, the
data suggest EC-derived RSPO3 as a regulator of blood vessel
stability by controlling vessel remodeling and EC apoptosis.
EC-Derived RSPO3 Regulates Tumor Vessel Stability
By deleting theWNT cargo transporter Evi/Wls, we have recently
identified EC-derived non-canonical WNT ligands as regulators
of vessel stability by interfering with vessel regression and EC
apoptosis (Korn et al., 2014). The striking phenotypic similarities
of Rspo3-iECKO and Evi-iECKO mice in postnatal develop-
mental angiogenesis led us to comparatively study pathological
tumor angiogenesis in Rspo3-iECKO and Evi-iECKOmice. Lewis
lung carcinomas (LLC) were grown in Rspo3-WT and Rspo3-DeveiECKO mice, and tamoxifen was given repeatedly after tumor
cell inoculation in order to induce Cre-mediated recombination
(Figure 4A). Similar to the LLC phenotype in Evi-iECKO mice
(Korn et al., 2014), the number of LLC tumor blood vessels was
reduced in Rspo3-iECKOmice (Figures 4B and 4C). Microvessel
density was also reduced in B16 melanoma tumors of Rspo3-
iECKO and Evi-iECKOmice compared withWT controls (Figures
4D, 4E, S3A, and S3B). Despite the reduction in tumor vessel
density, growth of LLC and B16 tumors was unaffected by
Rspo3 deletion from the vasculature (Figures S4A and S4C).
More detailed analysis of the vessel morphology revealed that
small- and medium-caliber vessels were reduced. By contrast,
the number of larger vessels remained constant in LLC and
B16 tumors of Rspo3-iECKOmice (Figures S4B and S4D), allow-
ing sufficient blood supply of the tumors.
Histological analysis identified more abundant ColIV staining
associated with blood vessels in Rspo3-iECKO and Evi-iECKO
tumors compared with WT tumors (Figures 4F and S3C, arrow-
heads). High-resolution microscopy showed that ColIV staining
hardly exceeded the vessel borders and had a smoothlopmental Cell 36, 79–93, January 11, 2016 ª2016 Elsevier Inc. 83
Figure 4. Reduced Tumor Vessel Density in
Rspo3-iECKO versus Rspo3-WT Mice
(A) Scheme of tumor cell implantation and tamoxifen
induction in Rspo3-WT and Rspo3-iECKO mice.
(B) LLC cryosections stained for CD31 (green) in
Rspo3-WT and Rspo3-iECKO mice.
(C) Analysis of the relative vessel number in LLC
tumors (n = 14).
(D) Cryosections of B16 melanomas stained for
CD31 (green) in Rspo3-WT and Rspo3-iECKO mice.
(E) Analysis of the relative vessel number in B16
tumors (n = 9).
(F) Representative images of B16 cryosections
stained for CD31 (green) and ColIV (red) in Rspo3-
WT and Rspo3-iECKO mice. Arrowheads mark
abundant ColIV-staining associated with blood
vessels.
(G) Analysis of the relative ColIV to CD31 area in B16
tumors (n = 9).
(H) Cryosections of B16 tumors stained for CD31
(green) and TIE2 (red) in Rspo3-WT and Rspo3-
iECKO mice. Arrowheads mark blood vessels with
low TIE2 expression.
(I) Analysis of the relative TIE2 to CD31 intensity
(n = 9).
(J) Cryosections of B16 melanomas stained for
TIE2 (gray) in Rspo3-WT and Rspo3-iECKO mice.
Arrowheads mark blood vessels with low TIE2
expression.
(K) Analysis of the relative CD31 intensity (n = 9).
Scale bars, 100 mm. Data are depicted as mean +
SD. p < 0.05 was considered statistically significant.
*p < 0.05, **p < 0.005, ***p < 0.001. See Figure S2 for
analysis of tumor vessel maturation in Rspo3- and
Evi-iECKO versus WT mice, and Figure S3 for vessel
analysis in B16 tumors grown in Evi-WT and Evi-
iECKO mice. See also Figure S4 for analysis of LLC
and B16 tumor weight as well as tumor vessel size in
Rspo3-WT and Rspo3-iECKO mice.
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appearance in Rspo3-WT tumors, whereas ColIV was more
widely distributed around the vessels and appeared rougher in
Rspo3-iECKO mice (Figure S4E). Similarly, the ratio of ColIV to
CD31 was increased upon deletion of Rspo3 and Evi/Wls (Fig-
ures 4G and S3D), indicating that EC-derived RSPO3 and EVI/
WLS regulate tumor blood vessel stability. Pericyte coverage
reflecting vessel maturation was not altered in Rspo3- or Evi/
Wls-deleted mice (Figures S2E–S2H).
Based on the observed downregulation of the survival
signaling receptor TEK/TIE2 in RSPO3-silenced EC (Figure 3G)
as well as in EVI/WLS-silenced EC (Korn et al., 2014), we also
analyzed TIE2 expression in tumor blood vessels. Tumors in
Rspo3-iECKO as well as in Evi-iECKO mice contained multiple
blood vessels with low TIE2 expression (Figures 4H, 4J, S3E,
and S3G, arrowheads) and a decreased TIE2 to CD31 intensity
ratio (Figures 4I and S3F). Total CD31 intensity remained con-
stant in the different experimental groups (Figures 4K and S3H).
EC-Derived RSPO3 Acts through Non-canonical WNT
Signaling
EVI/WLS regulates retinal and tumor blood vessel stability via
non-canonical WNT signaling (Korn et al., 2014). We conse-
quently examined which WNT downstream pathways were
controlled by EC-derived Rspo3. Analysis of canonical WNT
target gene expression in lung EC isolated from Rspo3-iECKO
mice revealed thatAxin2, Vegfa,Ccnd1, andMycwere not differ-
entially expressed upon Rspo3 deletion (Figures S5A and S5B).
Notch target genes have been shown to be upregulated upon
activation of canonical WNT signaling in EC (Corada et al.,
2010). Expression of the Notch target genes Dll4, Hey1, Hey2,
Jag1, Notch1, Notch4, and Nrarp remained constant in Rspo3-
iECKO mice (Figure S5C), further suggesting that canonical
WNT signaling was not primarily affected in lung EC of Rspo3-
iECKO mice.
To mechanistically unravel the contribution of non-canonical
WNT/PCP or WNT/Ca2+ signaling to the phenotype of Rspo3-
and Evi-iECKO mice, we performed comparative microarray an-
alyses with isolated EC from Rspo3-iECKO and Evi-iECKO mice
(original data have been deposited in the Gene Expression
Omnibus database; NCBI-GEO: GSE75836). A small cohort of
45 and 44 genes were differentially expressed in Rspo3- and
Evi-iECKOEC, respectively, comparedwithWTmice (Figure 5A).
Of these, nine genes were co-regulated in Rspo3-iECKO and
Evi-iECKO EC (Figures 5A and 5B). None of these has hitherto
been reported as target genes of WNT/PCP or WNT/Ca2+
signaling. Yet the second most differentially expressed gene,
Ring finger protein 213 (Rnf213) (Figures 5B and 5C), is a suscep-
tibility gene for the vascular disease Moyamoya and has been
reported to regulate vascular morphogenesis. Indeed, morpho-
lino silencing of RNF213 in zebrafish embryos results in aberrant
formation of dysmorphogenic blood vessels (Liu et al., 2011). We
consequently hypothesized that Rnf213 may be responsible for
the vascular phenotype of Rspo3-iECKO and Evi-iECKO mice.
Silencing ofRNF213Blocks Proteasomal Degradation of
Filamin A and NFAT1, Enhancing WNT/Ca2+
Downstream Signaling
The intrinsic E3 ubiquitin ligase activity of RNF213 (Liu et al.,
2009) prompted us to screen for non-canonical WNT down-Devestream mediators possibly being regulated by RNF213-medi-
ated proteasomal degradation. RNF213 co-immunoprecipita-
tion (coIP) experiments of HUVEC lysates confirmed RNF213
binding to ubiquitin in EC (Figure 5D). Moreover, the coIP exper-
iments identified filamin A and NFAT1/NFATc2 as RNF213
binding partners, which are both mediators of the WNT/Ca2+
pathway (De, 2011). Conversely, b-catenin did not bind to
RNF213 (Figure 5D).
We next silenced RNF213 in HUVEC to examine whether
RNF213 leads to proteasomal degradation of its interaction part-
ners. Filamin A as well as NFAT1 levels were increased upon
silencing of RNF213 compared with control siRNA (siScr), sug-
gesting reduced proteasomal degradation of these RNF213
target molecules in the absence of RNF213 (Figures 5E–5G). In
turn, b-catenin levels were not changed upon silencing of
RNF213 (Figure 5H). Blocking of proteasomal degradation
with the proteasome inhibitor bortezomib in RNF213-silenced
and control HUVEC identified filamin A and NFAT1 protein levels
in siScr control cells similar to the increased protein levels of
RNF213-silenced HUVEC (Figures 5I–5K), suggesting that
RNF213-dependent proteasomal degradation was rescued by
bortezomib. Again, protein levels of b-catenin were not changed
in RNF213-silenced HUVEC compared with siScr HUVEC upon
bortezomib treatment (Figure 5L). RT-qPCR analyses of filamin
A mRNA (FLNA) and NFAT1 further excluded major changes in
gene expression as a cause for the increased protein levels
upon silencing of RNF213 (Figures S6A–S6C).
NFAT1 is a transcription factor, which translocates to the
nucleus upon activation and induces target gene expression.
To elucidate whether silencing of RNF213 enhanced WNT/
Ca2+/NFAT signaling in HUVEC, we prepared cytoplasmic and
nuclear fractions for the detection of inactive versus active
NFAT1 by immunoblotting. NFAT1 levels were enhanced to the
same extent in the cytoplasmic and the nuclear fractions upon
siRNA-mediated silencing of RNF213 (Figure 5M), indicating
that accumulation in the cytoplasm directly resulted in the trans-
location to the nucleus. Activation of theWNT/Ca2+ pathway can
be mimicked by stimulation with the Ca2+ ionophore ionomycin.
When stimulating HUVEC with ionomycin, low levels of NFAT1
could be detected in the cytoplasm. Similarly to steady-state
conditions, NFAT1 levels increased in the nuclear fraction upon
RNF213 silencing in response to ionomycin (Figure 5M). Corre-
sponding to the nuclear translocation of NFAT1, expression of
the endothelial NFAT target genesCOX2 and IL-8were increased
upon stimulation with ionomycin (Figure 5N). Likewise, ionomy-
cin-induced COX2 and IL-8 expression was even higher upon
silencing of RNF213 compared with siScr control (Figure 5O).
Together, the data show that silencing ofRNF213 inhibits protea-
somal degradation of filamin A andNFAT1, subsequently leading
to increased NFAT1 signaling. Intriguingly, RNF213-deficient
mice express elevated levels of MMP-9 (Sonobe et al., 2014),
which is another NFAT target gene (Sundaram et al., 2007).
Silencing of USP18 and TRIM5a Ameliorates NFAT1
Activation and Downstream Signaling
Besides Rnf213, two of the co-regulated genes in Rspo3- and
Evi-iECKO mice may also be involved in NFAT signaling, namely
the ubiquitin-specific peptidase 18 (Usp18) and tripartite
motif containing 30a (Trim30a) (Figures 5B and S7). USP18lopmental Cell 36, 79–93, January 11, 2016 ª2016 Elsevier Inc. 85
Figure 5. Increased NFAT Protein Levels and Signaling upon siRNA-Mediated Silencing of RNF213
(A) Venn diagram of the regulated genes in lung EC from Rspo3-iECKO and Evi-iECKO versus WT mice as analyzed by microarray.
(B) List of the nine co-regulated genes in Rspo3- and Evi-iECKO lung EC according to their fold-changes in descending order (red color represents highest
upregulation).
(C) Gene expression analysis of lung EC Rnf213 from Rspo3-/Evi-WT and Rspo3-/Evi-iECKO mice with bact used as housekeeping gene (n = 8).
(D) Endogenous coIP was performed in HUVEC. Representative RNF213 coIP immunoblotting images of RNF213, ubiquitin, filamin A, NFAT1, and b-catenin.
(legend continued on next page)
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de-ubiquitinates TAK1, thereby blocking phosphorylation of
RCAN1, an inhibitor of calcineurin. RCAN1 serves as a facilitator
of calcineurin/NFAT signaling through phosphorylation by the
TAK1-TAB1-TAB2 complex (Liu et al., 2009). TRIM30a binds to
TAB2, leading to its lysosomal degradation and blocking
phosphorylation of RCAN1 (Shi et al., 2008). Thus, USP18 and
TRIM30a both inhibit RCAN1 phosphorylation and thereby
inhibit NFAT activation.
Usp18 upregulation in Rspo3- and Evi-iECKO lung EC was
validated by RT-qPCR (Figure 6A). To examine whether USP18
interfered with NFAT activation in EC, we silenced USP18 in
HUVEC using two different siRNAs (Figures 6B and 6C). Corre-
sponding to the RNF213 data, silencing of USP18 and stimula-
tion with ionomycin resulted in increased activation of NFAT1
as indicated by elevated NFAT1 levels in nuclear HUVEC frac-
tions (Figures 6D and 6E). Accordingly, ionomycin-induced upre-
gulation of COX2, and IL-8 was further increased upon silencing
of USP18 (Figure 6F). The analysis of total protein lysates of
USP18-silenced cells revealed an increase in the total amount
of NFAT1, which did not result from increased gene expression
(Figures 6G, 6H, S6D, and S6E).
Corresponding to the microarray data, Trim30a was upregu-
lated in Rspo3-iECKO and Evi-iECKO EC (Figure 6I). To explore
a possible role of TRIM30a in endothelial NFAT activation, we
silenced TRIM5a, the human equivalent to mouse Trim30a
(Tareen and Emerman, 2011), in HUVEC (Figures 6J and 6K).
Ionomycin-induced NFAT1 nuclear translocation as well as
COX2 and IL-8 upregulation were increased upon silencing of
TRIM5a (Figures 6L–6N). Moreover, total NFAT1 levels were
increased but gene expression was not affected (Figures 6O,
6P, S6F, and S6G). Elevated levels of TAB2 (Figure 6Q), which
were reversed by simultaneous stimulation with the lysosome in-
hibitor NH4Cl (Figures S6H and S6I), further confirmed TAB2
lysosomal degradation by TRIM5a. Together, the data demon-
strate that USP18 and TRIM5a attenuate NFAT1 activation in EC.
NFAT Levels Are Reduced in EC of Rspo3-iECKO Mice
The cellular experiments had identified a role of RNF213, USP18,
and TRIM5a in the regulation of NFAT1.Weconsequently hypoth-
esized that upregulation ofRnf213,Usp18,andTrim30a in Rspo3-
and Evi-iECKO mice may lead to attenuation of NFAT signaling.
Therefore, aortas of Rspo3-WT and Rspo3-iECKO p6 pups were
cut along their longitudinal axis and flat-mounted, allowing visual-
ization of NFAT1 distribution within the endothelial monolayer
stained for CD31 (Figure 7A). Corresponding to the enhanced
levels of NFAT1 upon silencing of RNF213, USP18, and TRIM5a
in vitro, cellular and nuclear NFAT1 levels were decreased in EC
of Rspo3-iECKO pups compared with Rspo3-WT pups at post-(E–H) Immunoblotting images and corresponding quantifications of RNF213 (E), fi
siRNA against RNF213. a-Tubulin was used as loading control.
(I–L) Immunoblotting images and corresponding quantifications of RNF213 (I), fil
siRNA against RNF213 and simultaneous incubation with Bortezomib for 48 hr. a
(M) Immunoblotting images and corresponding quantifications of NFAT1 from cy
(n = 5). Unstimulated cells were compared with cells stimulated with ionomycin f
(N) Gene expression analysis of COX2 and IL-8 from control and ionomycin-trea
(O) Gene expression analysis of COX2 and IL-8 from HUVEC treated with siRNA a
used as housekeeping gene.
Data are depicted asmean + SD. p < 0.05 was considered statistically significant.
expression in Rspo3-iECKO versus Rspo3-WT lung EC. See Figure S6 for NFAT
Devenatal day 6 (P6) (Figures 7B and 7C). However, the ratio between
total and nuclear NFAT1 remained unchanged (Figure 7D).
Blocking NFAT Activation by Cyclosporin A Treatment
Phenocopies Rspo3- and Evi-iECKO Mice
To analyze whether reduced NFAT signaling was responsible
for the vessel remodeling phenotype in Rspo3- and Evi-
iECKO mice, we studied retinal angiogenesis and vessel
remodeling in newborn mice treated with the calcineurin
inhibitor cyclosporin A (CsA) (Figure 7E). Phenocopying
Rspo3-iECKO mice, sprouting angiogenesis and the total
vascularized area were not affected by CsA treatment (Fig-
ures 7F–7H). However, these mice showed a reduction in
vessel area and vessel density, as well as in the number of
branches and branch points (Figures 7G–7K). Moreover,
CsA treatment led to an increase in the number of empty
ColIV sleeves (Figures 7L and 7M). Together, these data
demonstrate that NFAT blockade mimics the vessel remodel-
ing and regression phenotype of Rspo3- and Evi-iECKO mice
(Korn et al., 2014), thereby identifying RSPO3 as a regulator
of WNT/Ca2+/NFAT signaling.
DISCUSSION
The embryonic lethal vascular remodeling phenotype of Rspo3
mutant mice (Kazanskaya et al., 2008) suggests a role of EC-
derived RSPO3 in angiogenesis. We have recently shown that
EC-derived non-canonical WNT ligands regulate vascular re-
modeling (Korn et al., 2014). As R-spondins are frequently co-ex-
pressed with WNT ligands, this study was aimed at deciphering
the role of EC-derived RSPO3 in blood vessel development and
remodeling.
The experiments revealed that: (1) EC are the primary
source of RSPO3; (2) Rspo3-iECKO mice largely phenocopy
global Rspo3-deficient mice; (3) endothelial RSPO3 enhances
cell autonomous non-canonical Wnt signaling, thereby pre-
venting retinal and tumor blood vessel regression and EC
apoptosis; (4) loss of endothelial Rspo3 or Evi/Wls results
in upregulation of Rnf213, Usp18, and Trim30a, triggering
RNF213-mediated proteasomal degradation of NFAT1 as
well as USP18- and TRIM5a-controlled inhibition of NFAT1
activation; (5) NFAT levels are decreased in EC of Rspo3-
iECKO mice; and (6) pharmacological NFAT inhibition mimics
the retina vessel regression phenotype of Rspo3-iECKO and
Evi-iECKO mice.
The mid-gestational lethality of Rspo3-ECKOmice indicated a
role of EC-derived RSPO3 in controlling blood vessel remodel-
ing. In contrast to embryos with sprouting defects, dyinglamin A (F), NFAT1 (G), and b-catenin (H) (each n = 5) from HUVEC treated with
amin A (J), NFAT1 (K), and b-catenin (L) (each n = 5) from HUVEC treated with
-Tubulin was used as loading control.
toplasmic and nuclear fractions of HUVEC treated with siRNA against RNF213
or 2 hr. a-Tubulin and symplekin were used as loading controls.
ted HUVEC (n = 6).
gainst RNF213 and subsequent stimulation with ionomycin (n = 6). RPL32 was
*p < 0.05, **p < 0.005, ***p < 0.001. See Figure S5 for canonicalWNT target gene
and FLNA gene expression upon silencing of RNF213.
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Figure 6. IncreasedNFATProteinLevelsand
Signaling upon siRNA-Mediated Silencing
of USP18 and TRIM5a
(A) Gene expression analysis of lung EC from
Rspo3-/Evi-WT and Rspo3-/Evi-iECKO mice with
bact used as housekeeping gene (n = 8).
(B and C) Immunoblotting images (B) and corre-
sponding quantification (C) (n = 5) of USP18 from
HUVEC treated with siRNA against USP18.
a-Tubulin was used as loading control.
(D and E) Immunoblotting images (D) and corre-
sponding quantification (E) (n = 5) of NFAT1 from
nuclear fractions of HUVEC treated with siRNA
againstUSP18 upon 2 hr of ionomycin stimulation.
(F) Gene expression analysis of COX2 and IL-8
from HUVEC treated with siRNA against USP18
upon 2 hr of stimulation with ionomycin (n = 5).
B2M was used as housekeeping gene.
(G and H) Immunoblotting images (G) and corre-
sponding quantification (H) (n = 5) of NFAT1 from
HUVEC treated with siRNA against USP18.
a-Tubulin was used as loading control.
(I) Gene expression analysis of lung EC TRIM30a
from Rspo3-/Evi-WT and Rspo3-/Evi-iECKO mice
with bact used as housekeeping gene (n = 19).
(J and K) Immunoblotting images (J) and corre-
sponding quantification (K) (n = 5) of TRIM5a from
HUVEC treated with siRNA against TRIM5a.
a-Tubulin was used as loading control.
(L and M) Immunoblotting images (L) and corre-
sponding quantification (M) (n = 6) of NFAT1
from nuclear fractions of HUVEC treated with
siRNA against TRIM5a upon 2 hr of ionomycin
stimulation.
(N) Gene expression analysis of COX2 and IL-8
from HUVEC treated with siRNA against TRIM5a
upon 2 hr of stimulation with ionomycin (n = 5).
GAPDH was used as housekeeping gene.
(O–Q) Immunoblotting images (O) and corre-
sponding quantifications of NFAT1 (P) (n = 5) and
TAB2 (Q) (n = 5) from HUVEC treated with siRNA
against TRIM5a. a-Tubulin was used as loading
control.
Data are depicted as mean + SD. p < 0.05 was
considered statistically significant. *p < 0.05, **p <
0.005, ***p < 0.001. See Figure S6 for NFAT gene
expression upon silencing of USP18 and TRIM5a.between E8.5 and E9.5 (Shalaby et al., 1995), Rspo3-KO and
-ECKO mice survived until mid-gestation, resembling more the
vessel remodeling phenotype of Tie2 mutant embryos, which
die at E10.5 (Sato et al., 2008). Accordingly, formation of blood
vessels was normal in Rspo3 mutant mice, but vessels failed88 Developmental Cell 36, 79–93, January 11, 2016 ª2016 Elsevier Inc.to remodel thereafter (Kazanskaya et al.,
2008). Moreover, endothelial deletion of
Rspo3 resulted in defective vessel re-
modeling during postnatal retinal angio-
genesis and pathological tumor angio-
genesis, establishing endothelial RSPO3
as a regulator of blood vessel remodeling
and stability.
EC apoptosis was controlled by
RSPO3 independent of bystander cellsduring postnatal blood vessel remodeling. Moreover, endothelial
Rspo3 deletion resulted in reduced WNT/Ca2+ downstream
signaling in EC, together arguing for an autocrine function of
endothelial RSPO3. This is in line with the observation that R-
spondins are poorly released from the cell surface (Kazanskaya
Figure 7. RSPO3-Controlled NFAT-Dependent Blood Vessel Remodeling
(A) Flat-mounted endothelial monolayer of aortas stained for CD31 (green) and NFAT1 (red, gray) in Rspo3-WT and Rspo3-iECKO pups.
(B–D) Analysis of the relative NFAT intensity/cell (B), relative NFAT intensity/nucleus (C), and total/nuclear NFAT intensity (D) (n = 6).
(E) Scheme of CsA treatment in mouse pups.
(F) Sprouting front stained with IB-4 (green) in control and CsA-treated mice.
(G) Total retinal vasculature stained with IB-4 (green) in control and CsA-treated pups. The vascularized area is highlighted by a red line.
(H and I) Analysis of the relative vascularized area: vessel area (H) (n = 23) and vessel density (I) (n = 23).
(J and K) Analysis of the relative number of branches (J) (n = 23) and junctions (K) (n = 23).
(L) Retinal vasculature stained with IB-4 (green) and for ColIV (red) in control and CsA-treated mice. Empty ColIV BM sleeves are indicated by arrowheads.
(M) Analysis of the relative number of empty ColIV BM sleeves (n = 23).
Scale bars, 10 mm (A), 1 mm (F), and 100 mm (G and L). Data are depicted asmean + SD. p < 0.05 was considered statistically significant. **p < 0.005, ***p < 0.001.
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et al., 2004), mainly acting over short distances. In contrast, nu-
clear translocation of b-catenin was decreased in the allantois,
and the canonical WNT target gene Vegfa was downregulated
in placental trophoblast cells of Rspo3 mutant embryos (Kazan-
skaya et al., 2008), suggesting activation of canonical WNT
signaling by RSPO3 during embryonic development. Expression
of primarily non-canonical WNT ligands in retinal and lung EC
postnatally (Korn et al., 2014) explains the non-canonical WNT
phenotype observed in Rspo3-iECKO mice. Consequently,
primarily canonical WNT ligands may have been expressed in
the allantois and trophoblast during embryonic development,
explaining the canonical WNT phenotype in Rspo3 mutant
embryos. Besides the observed non-canonical WNT phenotype
in retinas and lungs of Rspo3-iECKO mice, these mice might
have additional canonical WNT phenotypes in vascular beds
expressing primarily canonical WNT ligands, such as the brain
(Liebner et al., 2008; Zhou and Nathans, 2014). Thus, functions
of endothelial RSPO3 in enhancing canonical or non-canonical
WNT signaling seem to be context dependent.
Canonical WNT and NOTCH target gene expression was not
affected in lung EC of Rspo3-iECKO EC, supporting the non-
canonical WNT phenotype observed in Rspo3-iECKO mice. In
turn, expression of TEK/TIE2, which is regulated by non-canon-
ical WNT5A (Masckauchan et al., 2006), was decreased upon
silencing of EC-derived Rspo3. With regard to the non-canonical
nature of the observed Rspo3-iECKO phenotype, compara-
tive gene expression analyses revealed upregulated levels of
Rnf213, Usp18, and Trim30a upon endothelial Rspo3 and
Evi/Wls deletion (Figures S7A and S7B). RNF213 was found to
regulate NFAT1 protein stability (Figure S7C), and USP18 and
TRIM30a served as regulators of NFAT1 activation via TAK1-
TAB1-TAB2 and RCAN1 (Figure S7D). Mimicking the Rspo3-
and Evi-iECKO phenotype by pharmacological blockade of
NFAT activation similarly identified a role of NFAT in vessel re-
modeling. Together, the data support a model of coordinated
function of endothelial RSPO3 and non-canonical WNT ligands
in activating non-canonical WNT/Ca2+/NFAT signaling to pre-
vent blood vessel regression (Figure S7E). R-spondins have pre-
viously been described to activate canonical WNT signaling and
WNT/PCP signaling (Glinka et al., 2011). This is consequently the
first study establishing a role of RSPO3 in the activation of the
WNT/Ca2+ pathway, which is one of the least characterized
WNT signaling pathways.
Understanding of the role of WNT/Ca2+/NFAT signaling during
angiogenesis is only beginning to emerge. The WNT signaling
modulator Secreted Frizzled-RelatedProtein 2 (SFRP2) activates
WNT/Ca2+ signaling in EC to stimulate angiogenesis (Courtwright
et al., 2009). Nfatc3/c4 double knockout mice as well as calci-
neurin B-deficient embryos die around E11. Similar to Rspo3-
ECKO embryos, blood vessels are formed normally, but vessels
are unstable and show disturbed remodeling (Graef et al.,
2001). Several NFAT target genes havebeen reported to promote
angiogenesis, includingCox2 and Il-8 (Li et al., 2003; Mena et al.,
2014). Functionally, NFAT may be regulated by shear stress. For
example, calcineurin/NFAT signaling is enhanced in lymphatic
EC upon oscillatory shear stress being necessary for the precise
regulation of lymphatic valve formation (Sabine et al., 2012).
Similarly, the NFAT target gene COX2 is upregulated in HUVEC
cultured under laminar flow (Topper et al., 1996). Increased90 Developmental Cell 36, 79–93, January 11, 2016 ª2016 Elsevier InNFATsignaling in response to flowcanbeexplainedby activation
of flow-sensitive Ca2+ channels upon mechanical forces (Yama-
moto and Ando, 2011). During blood vessel remodeling, regres-
sion is induced upon low-flow conditions (Korn and Augustin,
2015). Consequently, decreased NFAT signaling in Rspo3-
iECKO EC may functionally mimic low-flow conditions, resulting
in vessel regression. Moreover, decreased NFAT signaling leads
to EC apoptosis (Courtwright et al., 2009), whichmay additionally
destabilize blood vessels inRspo3- andEvi-iECKOmice.Beyond
RNF213 interactionwithNFAT1,RNF213binding to filaminA indi-
cated that endothelial filamin A levels were decreased in Rspo3-
iECKO mice. Cellular responses toward mechanical forces such
as low or high shear stress are mainly dependent on F-actin
cross-linked by filamin A, and filamin A is an important mechano-
sensor in vivo.Hence,mice lacking FLNA aremore susceptible to
force-induced apoptosis (Glogauer et al., 1998; Nakamura et al.,
2011). The loss of filamin A may therefore be causative for the
increased EC apoptosis in Rspo3-iECKO mice. Furthermore,
EC were possibly less sensitive to shear stress due to low filamin
A concentrations, thus also mimicking low-flow conditions, as
discussed above for NFAT.
RNF213 is a susceptibility gene for Moyamoya, an occlusive
cerebrovascular disease, being one of the major causes of
stroke in children and adults worldwide (Liu et al., 2011). Occlu-
sions appear in the internal carotid artery and its main branches
in the circle of Willis, resulting in the formation of a fine collateral
vascular network (Weinberg et al., 2011). A functional link be-
tween RNF213 mutations and Moyamoya disease has not yet
been established. However, the findings of this study strongly
suggest that NFAT signaling may be increased in EC of Moya-
moya patients due to insufficient proteasomal degradation by
mutated RNF213. In line with this hypothesis, several NFAT
target genes, such as MMP-2 and MMP-9, are upregulated
and levels of prostaglandin E2, which is synthesized by cycloox-
ygenase 2, are elevated in Moyamoya patients (Weinberg
et al., 2011). Furthermore, EC generated from induced pluripo-
tent stem cells of Moyamoya patients have higher levels of the
NFAT target gene IL-8 (Hitomi et al., 2013).
Little is known about the regulation of RNF213. A possible link
between RNF213 expression and blood flow has been sug-
gested on the basis of comparative evolutionary genome
sequencing analyses in humans and monkeys. RNF213 may
have facilitated hominid evolution by allowing increased oxygen
and glucose supply to the brain, which was necessary for the
formation of larger brains (Scally et al., 2012). Recently,
RNF213 upregulation has been identified upon stimulation with
interferon-b and -g (Kobayashi et al., 2015). Gene regulatory
experiments in cultured EC did not identify obvious mechanisms
of RNF213 regulation in the context of WNT signaling or blood
flow, e.g., laminar flow or direct stimulation with WNT ligands
(data not shown), suggesting that RNF213 regulation may not
be mimicked properly in 2D cell culture.
Overall, this study has established a role of non-canonical
WNT/Ca2+/NFAT signaling in the maintenance of vascular stabil-
ity, revealing fundamental insights into the mechanisms of
vessel remodeling (Figure S7). The data propose important
roles of cell-autonomously acting RSPO3 in EC. RNF213,
USP18, and TRIM5a were identified as critical regulators of
NFAT1 protein stability and activation. Lastly, the identificationc.
of NFAT1 as an RNF213 target opens avenues for further studies
aimed at unraveling the molecular pathogenesis of Moyamoya
disease.
EXPERIMENTAL PROCEDURES
Mice
Floxed Rspo3 mice were crossed to Sox2Cre mice for global Rspo3 deletion
(Rspo3-KO; Figure 1C), to Cdh5Cre mice for EC-specific Rspo3 deletion
(Rspo3-ECKO; Figure 1D), and to Cdh5CreERT2 mice for inducible EC-spe-
cific Rspo3 deletion (Rspo3-iECKO; Figure 2A). Floxed Evi/Wls mice were
crossed to Cdh5CreERT2 mice for inducible EC-specific Evi/Wls deletion
(Evi-iECKO).PDGFRbCremicewere crossed toROSA26YFPmice for isolation
of PDGFRb-positive pericytes by fluorescence-activated cell sorting (FACS).
To induce Rspo3 or Evi/Wls deletion in mouse pups, control and mutant litter-
mates were intragastrically injected with tamoxifen (Sigma T5648) at P1, P2,
and P3 (Figure 2B). For tumor experiments, 6-week-old control and mutant
mice were subcutaneously injected with 106 LLC cells or B16 melanoma cells.
To induce Rspo3 or Evi/Wls deletion after tumor cell implantation, control and
mutant animals were intraperitoneally treatedwith five doses of tamoxifen (Fig-
ure 4A). LLC and B16 tumors were harvested after 13 and 9 days, respectively,
and embedded in Tissue-Tek OCT compound. For CsA treatment, C57/Bl6
mouse pups were intraperitoneally injected with CsA (Sigma-Aldrich) at
P1, P3, and P5, and retinas were isolated at P6 (Figure 7E). For embryo anal-
ysis, miceweremated overnight and themorning of vaginal plug detection was
defined as E0.5. All animal experiments were approved by the local regula-
tory committee (Bezirksregierung Karlsruhe, Germany; permit #G240/12 and
#G107/12).
Cells
For siRNA-mediated silencing experiments, HUVEC were seeded in six-well
plates. After 24 hr, cells were transfected with Silencer select/Silencer siRNA
or control siRNA (Life Technologies). Mediumwas changed to HUVECmedium
after 4 hr. Gene expression or immunoblot analyses were performed after 72 hr
unless otherwise stated.
Retina Assay
For retina analyses, mice were euthanized at P6. Eyeballs were isolated and
fixed in either ice-cold methanol or in 4% paraformaldehyde (PFA). The retinal
vasculature was visualized with fluorescein isothiocyanate-conjugated IB-4
(Sigma) or by staining for CD31. Pictures were taken using Zeiss LSM700
confocal microscope, and image analysis was accomplished with Fiji.
Aorta Whole-Mount Staining
For aorta analysis, mice were euthanized at P6 and aortas were resected. The
endothelial monolayer was visualized by staining for the junctional marker
CD31. Aortas were cut along their longitudinal axis and flat-mounted onmicro-
scope slides. Pictures were taken using Zeiss LSM700 and image analysis was
accomplished with Fiji.
EC and Pericyte Isolation
EC isolation from lungs of P6 pups was performed as described previously
(Korn et al., 2014). In brief, mice were euthanized, and lungs were removed
and cut into small pieces. Organs were digested and single-cell suspensions
were prepared. Cells were stained for the negative markers Podoplanin/
LYVE-1/CD45/TER119. Negatively stained cells were depleted by incubation
with Dynabeads magnetic beads (Life Technologies). The remaining cells
were positively stained with antibodies against CD31 and CD34. Dead cells
were excluded by propidium iodide (PI) staining. CD45, TER119, LYVE-
1, Podoplanin, PI, CD31+, and CD34+ cells were sorted with a BD Biosci-
ences FACSAria cell sorter (DKFZ core facility). For isolation of pericytes and
EC from lungs, hearts, and kidneys of P6-old PDGFRbCre-ROSA26YFP
pups, three to five organs were pooled per sample. The protocol was per-
formed as described for isolation of EC from lungs. CD45, TER119,
Podoplanin, FxCycle, and CD31+ EC and CD45, TER119, Podoplanin,
CD31, FxCycle, and YFP+ pericytes were sorted with the BD Biosciences
FACSAria cell sorter.DeveImmunofluorescence Staining and Analyses
Cryosections were fixed in ice-coldmethanol or in 4%PFA. Cryosectionswere
incubated with the indicated antibodies overnight at 4C. Incubation with the
appropriate secondary antibody was performed for 1 hr at room temperature.
Pictures were taken using Zeiss Cell Observer and image analysis was accom-
plished with Fiji.
Microarrays
Microarrays were performed by the DKFZ genomic core facility. Quality and
concentration of total RNA was checked by gel analysis using the Agilent
RNA 6000 Pico Kit on an Agilent 2100 Bioanalyzer. cDNA was amplified using
NuGEN SPIA (Single Primer Isothermal Amplification) technology. Biotin-
labeled cDNA was hybridized afterward on Illumina Mouse Sentrix-6
(Version-2) arrays according to the manufacturer’s instructions. Microarray
data were collected with an iScan array scanner and analyzed using Chipster
software.
Immunoprecipitation and Immunoblotting Analysis
Co-IP assays were performed using Crosslink Magnetic IP and Co-IP Kit
(Pierce) according to the manufacturer’s instructions. Nuclear and
cytoplasmic fractions were obtained using NE-PER Nuclear and Cyto-
plasmic Extraction Reagents (Pierce) according to the manufacturer’s
protocols. Protein lysates were separated on either 5% or 10% poly-
acrylamide-SDS gels, blotted on polyvinylidene fluoride membranes,
and incubated with the indicated primary antibodies. Horseradish perox-
idase-conjugated secondary antibodies were used for chemilumines-
cence detection.
Detailed descriptions of all procedures are given in Supplemental Experi-
mental Procedures.
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